back to top
- XBP1s: Getting to the Roots of Multiple MyelomaJune 03, 2019 | July-August 2019, Volume 16, Issue 4
Drs. Dong, Tahri, and Ghobrial discuss using the B cell-specific XBP-1 transgenic murine model to define a plasma cell progenitor cells population in multiple myeloma.
- In Search of Missed Tumors: Next-Generation Sequencing for Minimal Residual Disease Detection in Multiple Myeloma Comes of AgeDecember 21, 2018 | January-February 2019, Volume 16, Issue 1
Dr. Sklavenitis-Pistofidis, Dr. Dong, and Dr. Ghobrial discuss developments in the use next-generation sequencing for minimal residual disease detection in multiple myeloma.
Dr. Dong is a PhD Research Fellow in Medical Oncology at Dana-Farber Cancer Institute.